Abcellera Debt Ratio from 2010 to 2024

ABCL Stock  USD 3.86  0.01  0.26%   
Abcellera BiologicsInc Debt Ratio yearly trend continues to be quite stable with very little volatility. The value of Debt Ratio is projected to decrease to 0.05. From the period between 2010 and 2024, Abcellera BiologicsInc, Debt Ratio regression line of its data series had standard deviation of  0.07 and standard deviation of  0.07. View All Fundamentals
 
Debt Ratio  
First Reported
2010-12-31
Previous Quarter
0.0519994
Current Value
0.0494
Quarterly Volatility
0.07492139
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Abcellera BiologicsInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abcellera main balance sheet or income statement drivers, such as Net Interest Income of 44.4 M, Interest Income of 44.4 M or Depreciation And Amortization of 20.4 M, as well as many exotic indicators such as Price To Sales Ratio of 41.25, Dividend Yield of 0.0 or PTB Ratio of 1.36. Abcellera financial statements analysis is a perfect complement when working with Abcellera BiologicsInc Valuation or Volatility modules.
  
This module can also supplement Abcellera BiologicsInc's financial leverage analysis and stock options assessment as well as various Abcellera BiologicsInc Technical models . Check out the analysis of Abcellera BiologicsInc Correlation against competitors.
For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.

Latest Abcellera BiologicsInc's Debt Ratio Growth Pattern

Below is the plot of the Debt Ratio of Abcellera BiologicsInc over the last few years. It is Abcellera BiologicsInc's Debt Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Abcellera BiologicsInc's overall financial position and show how it may be relating to other accounts over time.
Debt Ratio10 Years Trend
Slightly volatile
   Debt Ratio   
       Timeline  

Abcellera Debt Ratio Regression Statistics

Arithmetic Mean0.13
Geometric Mean0.1
Coefficient Of Variation58.34
Mean Deviation0.06
Median0.16
Standard Deviation0.07
Sample Variance0.01
Range0.2873
R-Value(0.57)
Mean Square Error0
R-Squared0.32
Significance0.03
Slope(0.01)
Total Sum of Squares0.08

Abcellera Debt Ratio History

2024 0.0494
2023 0.052
2022 0.0534
2021 0.0304
2020 0.006069
2019 0.29

Other Fundumenentals of Abcellera BiologicsInc

Abcellera BiologicsInc Debt Ratio component correlations

1.00.950.82-0.690.960.990.960.710.991.0-0.970.990.990.990.60.990.850.89-0.50.90.520.76-0.66
1.00.950.82-0.70.960.990.960.710.991.0-0.980.990.990.990.590.990.840.88-0.50.890.520.76-0.66
0.950.950.93-0.540.910.930.890.650.950.95-0.970.940.940.940.620.940.940.92-0.390.910.30.81-0.84
0.820.820.93-0.230.830.770.740.360.830.82-0.820.780.780.780.750.770.990.9-0.150.920.070.92-0.97
-0.69-0.7-0.54-0.23-0.58-0.73-0.73-0.91-0.63-0.70.74-0.77-0.77-0.770.11-0.77-0.24-0.320.57-0.34-0.56-0.110.02
0.960.960.910.83-0.580.970.880.530.960.96-0.90.940.910.940.720.910.870.9-0.520.950.570.8-0.66
0.990.990.930.77-0.730.970.940.720.980.99-0.960.990.980.990.570.980.820.87-0.620.890.610.68-0.6
0.960.960.890.74-0.730.880.940.760.950.96-0.940.960.970.960.510.970.750.81-0.440.790.510.69-0.57
0.710.710.650.36-0.910.530.720.760.670.72-0.810.770.80.77-0.110.80.360.42-0.510.360.380.15-0.22
0.990.990.950.83-0.630.960.980.950.670.99-0.960.980.970.980.660.970.870.93-0.520.920.550.78-0.68
1.01.00.950.82-0.70.960.990.960.720.99-0.980.990.990.990.590.990.840.88-0.50.890.520.75-0.66
-0.97-0.98-0.97-0.820.74-0.9-0.96-0.94-0.81-0.96-0.98-0.98-0.99-0.98-0.46-0.99-0.82-0.840.49-0.83-0.41-0.680.68
0.990.990.940.78-0.770.940.990.960.770.980.99-0.981.01.00.511.00.80.84-0.530.850.530.69-0.61
0.990.990.940.78-0.770.910.980.970.80.970.99-0.991.00.990.481.00.790.83-0.490.830.490.68-0.61
0.990.990.940.78-0.770.940.990.960.770.980.99-0.981.00.990.510.990.80.84-0.530.850.530.69-0.6
0.60.590.620.750.110.720.570.51-0.110.660.59-0.460.510.480.510.470.810.84-0.220.860.350.86-0.71
0.990.990.940.77-0.770.910.980.970.80.970.99-0.991.01.00.990.470.790.83-0.490.830.490.68-0.61
0.850.840.940.99-0.240.870.820.750.360.870.84-0.820.80.790.80.810.790.95-0.290.960.20.91-0.94
0.890.880.920.9-0.320.90.870.810.420.930.88-0.840.840.830.840.840.830.95-0.460.970.440.86-0.82
-0.5-0.5-0.39-0.150.57-0.52-0.62-0.44-0.51-0.52-0.50.49-0.53-0.49-0.53-0.22-0.49-0.29-0.46-0.43-0.840.010.0
0.90.890.910.92-0.340.950.890.790.360.920.89-0.830.850.830.850.860.830.960.97-0.430.430.89-0.81
0.520.520.30.07-0.560.570.610.510.380.550.52-0.410.530.490.530.350.490.20.44-0.840.430.120.14
0.760.760.810.92-0.110.80.680.690.150.780.75-0.680.690.680.690.860.680.910.860.010.890.12-0.87
-0.66-0.66-0.84-0.970.02-0.66-0.6-0.57-0.22-0.68-0.660.68-0.61-0.61-0.6-0.71-0.61-0.94-0.820.0-0.810.14-0.87
Click cells to compare fundamentals

About Abcellera BiologicsInc Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Abcellera BiologicsInc income statement, its balance sheet, and the statement of cash flows. Abcellera BiologicsInc investors use historical funamental indicators, such as Abcellera BiologicsInc's Debt Ratio, to determine how well the company is positioned to perform in the future. Although Abcellera BiologicsInc investors may use each financial statement separately, they are all related. The changes in Abcellera BiologicsInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Abcellera BiologicsInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Abcellera BiologicsInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Abcellera BiologicsInc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Debt Ratio 0.05  0.05 
Cash Flow To Debt Ratio(0.57)(0.54)

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Abcellera BiologicsInc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Abcellera BiologicsInc is a strong investment it is important to analyze Abcellera BiologicsInc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Abcellera BiologicsInc's future performance. For an informed investment choice regarding Abcellera Stock, refer to the following important reports:
Check out the analysis of Abcellera BiologicsInc Correlation against competitors.
For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.
Note that the Abcellera BiologicsInc information on this page should be used as a complementary analysis to other Abcellera BiologicsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Abcellera Stock analysis

When running Abcellera BiologicsInc's price analysis, check to measure Abcellera BiologicsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abcellera BiologicsInc is operating at the current time. Most of Abcellera BiologicsInc's value examination focuses on studying past and present price action to predict the probability of Abcellera BiologicsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abcellera BiologicsInc's price. Additionally, you may evaluate how the addition of Abcellera BiologicsInc to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Is Abcellera BiologicsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcellera BiologicsInc. If investors know Abcellera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abcellera BiologicsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.459
Earnings Share
(0.51)
Revenue Per Share
0.131
Quarterly Revenue Growth
(0.57)
Return On Assets
(0.1)
The market value of Abcellera BiologicsInc is measured differently than its book value, which is the value of Abcellera that is recorded on the company's balance sheet. Investors also form their own opinion of Abcellera BiologicsInc's value that differs from its market value or its book value, called intrinsic value, which is Abcellera BiologicsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcellera BiologicsInc's market value can be influenced by many factors that don't directly affect Abcellera BiologicsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abcellera BiologicsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Abcellera BiologicsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcellera BiologicsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.